Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Report

China Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry Market Research Report 2023-2029

  • POSTDATE：Oct 13, 2023
  • PAGES：203
  • REPORT CODE：GMM1851905
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Coronavirus (COVID 19) Vaccine Pipeline Assessment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Clover Biopharmaceuticals/Dynavax/GlaxoSmithKline

    • Heat Biologics Inc/University of Miami

    • Medicago

    • Vaxil Bio Therapeutics

    • Flow Pharma Inc

    • Cobra Biologics/Karolinska Institute

    • Takis Biotech/Applied DNA Sciences/Evvivax

    • VIDO-InterVac/University of Saskatchewan/International Vaccine Institute

    • Tonix Pharmaceuticals/Southern Research

    • Inovio Pharmaceuticals Inc

    • IAVI/Batavia Biosciences

    • University of Oxford

    • Moderna/NIAID

    • Vaxart Inc

    • BioNet Asia

    • Immunomic Therapeutics/EpiVax/PharmaJet

    • Sanofi Pasteur/GlaxoSmithKline (GSK)

    • Zydus Cadila

    • Greffex

    • Sinovac/Dynavax

    • CanSino Biological Inc/Beijing Institute of Biotechnology

    • Generex Biotechnology/EpiVax

    • Sanofi Pasteur/Translate Bio Inc

    • ExpreS2ion Biotechnologies ApS

    • BioNTech/Pfizer/Fosun Pharma

    • Altimmune

    • Curevac

    • Arcturus Therapeutics/Duke-NUS

    • Novavax

    • Imophoron Ltd/University of Bristol

    • iBio Inc/CC-Pharming Ltd/Infectious Disease Research Institute

    • GeoVax/BravoVax

    By Type:

    • Type 1

    • Type 2

    • Type 3

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Overview 2018-2029

    • 1.1 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry Development Overview

    • 1.2 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry Development History

    • 1.3 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry Market Size (2018-2029)

    • 1.4 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Analysis by Type from Production Side

      • 1.4.1 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

      • 1.4.2 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

      • 1.4.3 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • 1.5 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Analysis by Application from Consumption End

      • 1.5.1 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Analysis by Region

      • 1.6.1 North China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Status and Competition Analysis in 2023

      • 2.2.3 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry Development

    Chapter 3 Coronavirus (COVID 19) Vaccine Pipeline AssessmentIndustry Chain Analysis

    • 3.1 Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry Chain

    • 3.2 Coronavirus (COVID 19) Vaccine Pipeline Assessment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Coronavirus (COVID 19) Vaccine Pipeline Assessment Market

    • 3.3 Coronavirus (COVID 19) Vaccine Pipeline Assessment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Coronavirus (COVID 19) Vaccine Pipeline Assessment Market

    Chapter 4 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Type

    • 4.1 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume and Growth Rate, by Type

      • 4.5.1 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume and Growth Rate of Type 1

      • 4.5.2 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume and Growth Rate of Type 2

      • 4.5.3 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume and Growth Rate of Type 3

    Chapter 5 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate, by Application

      • 5.5.1 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate of Application 1

      • 5.5.2 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate of Application 2

      • 5.5.3 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate of Application 3

    Chapter 6 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Region

    • 6.1 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume and Production Value, by Region

    • 6.2 China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume and Sales Value, by Region

    Chapter 7 North China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Analysis

    • 7.1 North China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Type

    • 7.2 North China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Application

    Chapter 8 Central China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Analysis

    • 8.1 Central China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Type

    • 8.2 Central China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Application

    Chapter 9 South China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Analysis

    • 9.1 South China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Type

    • 9.2 South China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Application

    Chapter 10 East China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Analysis

    • 10.1 East China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Type

    • 10.2 East China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Application

    Chapter 11 Northeast China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Analysis

    • 11.1 Northeast China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Type

    • 11.2 Northeast China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Application

    Chapter 12 Southwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Analysis

    • 12.1 Southwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Type

    • 12.2 Southwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Application

    Chapter 13 Northwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Analysis

    • 13.1 Northwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Type

    • 13.2 Northwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Clover Biopharmaceuticals/Dynavax/GlaxoSmithKline

        • 14.1.1 Clover Biopharmaceuticals/Dynavax/GlaxoSmithKline Company Profile

        • 14.1.2 Clover Biopharmaceuticals/Dynavax/GlaxoSmithKline Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Heat Biologics Inc/University of Miami

        • 14.2.1 Heat Biologics Inc/University of Miami Company Profile

        • 14.2.2 Heat Biologics Inc/University of Miami Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Medicago

        • 14.3.1 Medicago Company Profile

        • 14.3.2 Medicago Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Vaxil Bio Therapeutics

        • 14.4.1 Vaxil Bio Therapeutics Company Profile

        • 14.4.2 Vaxil Bio Therapeutics Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Flow Pharma Inc

        • 14.5.1 Flow Pharma Inc Company Profile

        • 14.5.2 Flow Pharma Inc Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Cobra Biologics/Karolinska Institute

        • 14.6.1 Cobra Biologics/Karolinska Institute Company Profile

        • 14.6.2 Cobra Biologics/Karolinska Institute Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Takis Biotech/Applied DNA Sciences/Evvivax

        • 14.7.1 Takis Biotech/Applied DNA Sciences/Evvivax Company Profile

        • 14.7.2 Takis Biotech/Applied DNA Sciences/Evvivax Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 VIDO-InterVac/University of Saskatchewan/International Vaccine Institute

        • 14.8.1 VIDO-InterVac/University of Saskatchewan/International Vaccine Institute Company Profile

        • 14.8.2 VIDO-InterVac/University of Saskatchewan/International Vaccine Institute Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Tonix Pharmaceuticals/Southern Research

        • 14.9.1 Tonix Pharmaceuticals/Southern Research Company Profile

        • 14.9.2 Tonix Pharmaceuticals/Southern Research Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Inovio Pharmaceuticals Inc

        • 14.10.1 Inovio Pharmaceuticals Inc Company Profile

        • 14.10.2 Inovio Pharmaceuticals Inc Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 IAVI/Batavia Biosciences

        • 14.11.1 IAVI/Batavia Biosciences Company Profile

        • 14.11.2 IAVI/Batavia Biosciences Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 University of Oxford

        • 14.12.1 University of Oxford Company Profile

        • 14.12.2 University of Oxford Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Moderna/NIAID

        • 14.13.1 Moderna/NIAID Company Profile

        • 14.13.2 Moderna/NIAID Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Vaxart Inc

        • 14.14.1 Vaxart Inc Company Profile

        • 14.14.2 Vaxart Inc Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 BioNet Asia

        • 14.15.1 BioNet Asia Company Profile

        • 14.15.2 BioNet Asia Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Immunomic Therapeutics/EpiVax/PharmaJet

        • 14.16.1 Immunomic Therapeutics/EpiVax/PharmaJet Company Profile

        • 14.16.2 Immunomic Therapeutics/EpiVax/PharmaJet Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Sanofi Pasteur/GlaxoSmithKline (GSK)

        • 14.17.1 Sanofi Pasteur/GlaxoSmithKline (GSK) Company Profile

        • 14.17.2 Sanofi Pasteur/GlaxoSmithKline (GSK) Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Zydus Cadila

        • 14.18.1 Zydus Cadila Company Profile

        • 14.18.2 Zydus Cadila Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Greffex

        • 14.19.1 Greffex Company Profile

        • 14.19.2 Greffex Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Sinovac/Dynavax

        • 14.20.1 Sinovac/Dynavax Company Profile

        • 14.20.2 Sinovac/Dynavax Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 CanSino Biological Inc/Beijing Institute of Biotechnology

        • 14.21.1 CanSino Biological Inc/Beijing Institute of Biotechnology Company Profile

        • 14.21.2 CanSino Biological Inc/Beijing Institute of Biotechnology Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Generex Biotechnology/EpiVax

        • 14.22.1 Generex Biotechnology/EpiVax Company Profile

        • 14.22.2 Generex Biotechnology/EpiVax Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.22.3 Product&Service Introduction

      • 14.23 Sanofi Pasteur/Translate Bio Inc

        • 14.23.1 Sanofi Pasteur/Translate Bio Inc Company Profile

        • 14.23.2 Sanofi Pasteur/Translate Bio Inc Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.23.3 Product&Service Introduction

      • 14.24 ExpreS2ion Biotechnologies ApS

        • 14.24.1 ExpreS2ion Biotechnologies ApS Company Profile

        • 14.24.2 ExpreS2ion Biotechnologies ApS Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.24.3 Product&Service Introduction

      • 14.25 BioNTech/Pfizer/Fosun Pharma

        • 14.25.1 BioNTech/Pfizer/Fosun Pharma Company Profile

        • 14.25.2 BioNTech/Pfizer/Fosun Pharma Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.25.3 Product&Service Introduction

      • 14.26 Altimmune

        • 14.26.1 Altimmune Company Profile

        • 14.26.2 Altimmune Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.26.3 Product&Service Introduction

      • 14.27 Curevac

        • 14.27.1 Curevac Company Profile

        • 14.27.2 Curevac Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.27.3 Product&Service Introduction

      • 14.28 Arcturus Therapeutics/Duke-NUS

        • 14.28.1 Arcturus Therapeutics/Duke-NUS Company Profile

        • 14.28.2 Arcturus Therapeutics/Duke-NUS Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.28.3 Product&Service Introduction

      • 14.29 Novavax

        • 14.29.1 Novavax Company Profile

        • 14.29.2 Novavax Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.29.3 Product&Service Introduction

      • 14.30 Imophoron Ltd/University of Bristol

        • 14.30.1 Imophoron Ltd/University of Bristol Company Profile

        • 14.30.2 Imophoron Ltd/University of Bristol Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.30.3 Product&Service Introduction

      • 14.31 iBio Inc/CC-Pharming Ltd/Infectious Disease Research Institute

        • 14.31.1 iBio Inc/CC-Pharming Ltd/Infectious Disease Research Institute Company Profile

        • 14.31.2 iBio Inc/CC-Pharming Ltd/Infectious Disease Research Institute Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.31.3 Product&Service Introduction

      • 14.32 GeoVax/BravoVax

        • 14.32.1 GeoVax/BravoVax Company Profile

        • 14.32.2 GeoVax/BravoVax Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Performance

        • 14.32.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry Research Conclusions

    • 15.2 Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry Market Size (2018-2029)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

    • Figure Central China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

    • Figure South China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

    • Figure East China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate from 2018-2029

    • Figure Coronavirus (COVID 19) Vaccine Pipeline Assessment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Share by Type in 2018

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Share by Type in 2023

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume and Growth Rate of Type 1 (2018-2023)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume and Growth Rate of Type 2 (2018-2023)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume and Growth Rate of Type 3 (2018-2023)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Share by Application in 2018

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Share by Application in 2023

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Total Market Size and Growth Rate from Consumption End

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume by Region (2018-2023)

    • Table China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Region (2018-2023)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Region (2018-2023)

    • Table China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Value by Region (2018-2023)

    • Table China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Value Share by Region (2018-2023)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Value Share by Region (2018-2023)

    • Table China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume by Region (2018-2023)

    • Table China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Region (2018-2023)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Region (2018-2023)

    • Table China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Value by Region (2018-2023)

    • Table China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Value Share by Region (2018-2023)

    • Figure China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Value Share by Region (2018-2023)

    • Table North China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume by Type (2018-2023)

    • Table North China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Figure North China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Table North China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume by Application (2018-2023)

    • Table North China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Figure North China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Table Central China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume by Type (2018-2023)

    • Table Central China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Figure Central China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Table Central China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume by Application (2018-2023)

    • Table Central China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Figure Central China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Table South China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume by Type (2018-2023)

    • Table South China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Figure South China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Table South China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume by Application (2018-2023)

    • Table South China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Figure South China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Table East China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume by Type (2018-2023)

    • Table East China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Figure East China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Table East China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume by Application (2018-2023)

    • Table East China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Figure East China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume by Type (2018-2023)

    • Table Northeast China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Table Northeast China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume by Application (2018-2023)

    • Table Northeast China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume by Type (2018-2023)

    • Table Southwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Table Southwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume by Application (2018-2023)

    • Table Southwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume by Type (2018-2023)

    • Table Northwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Production Volume Share by Type (2018-2023)

    • Table Northwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume by Application (2018-2023)

    • Table Northwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Coronavirus (COVID 19) Vaccine Pipeline Assessment Sales Volume Share by Application (2018-2023)

    • Table Clover Biopharmaceuticals/Dynavax/GlaxoSmithKline Company Profile

    • Table Clover Biopharmaceuticals/Dynavax/GlaxoSmithKline Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Heat Biologics Inc/University of Miami Company Profile

    • Table Heat Biologics Inc/University of Miami Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Medicago Company Profile

    • Table Medicago Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Vaxil Bio Therapeutics Company Profile

    • Table Vaxil Bio Therapeutics Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Flow Pharma Inc Company Profile

    • Table Flow Pharma Inc Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Cobra Biologics/Karolinska Institute Company Profile

    • Table Cobra Biologics/Karolinska Institute Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Takis Biotech/Applied DNA Sciences/Evvivax Company Profile

    • Table Takis Biotech/Applied DNA Sciences/Evvivax Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table VIDO-InterVac/University of Saskatchewan/International Vaccine Institute Company Profile

    • Table VIDO-InterVac/University of Saskatchewan/International Vaccine Institute Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Tonix Pharmaceuticals/Southern Research Company Profile

    • Table Tonix Pharmaceuticals/Southern Research Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Inovio Pharmaceuticals Inc Company Profile

    • Table Inovio Pharmaceuticals Inc Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table IAVI/Batavia Biosciences Company Profile

    • Table IAVI/Batavia Biosciences Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table University of Oxford Company Profile

    • Table University of Oxford Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Moderna/NIAID Company Profile

    • Table Moderna/NIAID Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Vaxart Inc Company Profile

    • Table Vaxart Inc Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table BioNet Asia Company Profile

    • Table BioNet Asia Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Immunomic Therapeutics/EpiVax/PharmaJet Company Profile

    • Table Immunomic Therapeutics/EpiVax/PharmaJet Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Sanofi Pasteur/GlaxoSmithKline (GSK) Company Profile

    • Table Sanofi Pasteur/GlaxoSmithKline (GSK) Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Zydus Cadila Company Profile

    • Table Zydus Cadila Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Greffex Company Profile

    • Table Greffex Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Sinovac/Dynavax Company Profile

    • Table Sinovac/Dynavax Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table CanSino Biological Inc/Beijing Institute of Biotechnology Company Profile

    • Table CanSino Biological Inc/Beijing Institute of Biotechnology Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Generex Biotechnology/EpiVax Company Profile

    • Table Generex Biotechnology/EpiVax Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Sanofi Pasteur/Translate Bio Inc Company Profile

    • Table Sanofi Pasteur/Translate Bio Inc Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table ExpreS2ion Biotechnologies ApS Company Profile

    • Table ExpreS2ion Biotechnologies ApS Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table BioNTech/Pfizer/Fosun Pharma Company Profile

    • Table BioNTech/Pfizer/Fosun Pharma Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Altimmune Company Profile

    • Table Altimmune Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Curevac Company Profile

    • Table Curevac Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Arcturus Therapeutics/Duke-NUS Company Profile

    • Table Arcturus Therapeutics/Duke-NUS Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Novavax Company Profile

    • Table Novavax Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table Imophoron Ltd/University of Bristol Company Profile

    • Table Imophoron Ltd/University of Bristol Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table iBio Inc/CC-Pharming Ltd/Infectious Disease Research Institute Company Profile

    • Table iBio Inc/CC-Pharming Ltd/Infectious Disease Research Institute Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)

    • Table GeoVax/BravoVax Company Profile

    • Table GeoVax/BravoVax Coronavirus (COVID 19) Vaccine Pipeline Assessment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US